. 2019 Nov 19;21(12):1771–1779. doi: 10.1111/jch.13728

Table 2.

Clinical and anthropometric characteristics displayed by quartiles of salt intake in the entire sample

	Estimated salt intake (n = 7755)
	Q1	Q2	Q3	Q4	P for trend
Age (y)	49.3 ± 8.4	49.9 ± 8.4	50.3 ± 8.4^*	49.7 ± 8.2	.001
Weight (kg)	67.6 ± 12.6	70.1 ± 13.3^*	72.0 ± 13.4^* ^, ^**	75.7 ± 14.2^* ^, ^ ^, *	<.001
Height (cm)	164.9 ± 9.2	165.4 ± 9.3	165.3 ± 9.4	166.2 ± 9.4^* ^, ^ ^, *	<.001
BMI (kg/m²)	24.8 ± 3.8	25.5 ± 3.9^*	26.3 ± 4.1^* ^, ^**	27.3 ± 4.3^* ^, ^ ^, *	<.001
Uric acid (mg/dL)	5.3 ± 1.4	53.2 ± 1.4	5.3 ± 1.4	5.3 ± 1.4	.786
Glucose (mg/dL)	104.6 ± 16.3	105.0 ± 19.2	107.9 ± 25.9^* ^, ^**	110.4 ± 28.2^* ^, ^ ^, *	<.001
Cholesterol (mg/dL)	213.9 ± 40.2	214.9 ± 40.0	214.7 ± 41.8	214.9 ± 43.2	.862
HDL (mg/dL)	58.1 ± 14.7	57.9 ± 15.1	57.3 ± 14.2	57.1 ± 14.4	.105
LDL (mg/dL)	132.7 ± 34.4	132.5 ± 34.1	132.0 ± 34.6	130.6 ± 34.1	.257
TG (mg/dL)	117.7 ± 71.0	123.6 ± 77.0	129.5 ± 89.0^*	141.4 ± 140.1^* ^, ^ ^, *	<.001
GFR (mL/min per 1.73 m²)	95.2 ± 16.0	95.0 ± 15.9	94.7 ± 16.0	95.3 ± 15.7	.707
K excretion (mg/d)	1961 ± 842	2194 ± 843^*	2454 ± 949^* ^, ^**	2819 ± 1049^* ^, ^ ^, *	<.001
cf‐PWV (m/s)	8.7 ± 1.4	8.8 ± 1.4^*	8.9 ± 1.4^*	9.0 ± 1.4^* ^, ^**	<.001
SBP (mm Hg)	112.7 ± 11.3	113.9 ± 11.4^*	114.9 ± 11.2^* ^, ^**	115.9 ± 11.3^* ^, ^**	<.001
DBP (mm Hg)	71.5 ± 8.1	72.2 ± 8.0^*	72.9 ± 8.0^* ^, ^**	74.0 ± 7.9^* ^, ^ ^, *	<.001
HR (bpm)	70.0 ± 10.1	69.7 ± 9.5	70.3 ± 9.6	70.6 ± 9.8^**	.039

Abbreviations: BMI, body mass index; cf‐PWV, carotid‐femoral pulse wave velocity; DBP, diastolic blood pressure; GFR, glomerular filtration rate; HDL, high‐density lipoprotein; HR, heart rate; LDL, low‐density lipoprotein; SBP, systolic blood pressure; TG, triglycerides.

P < .05 vs Q1.

^**

P < .05 vs Q2.

^***

P < .05 vs Q3.